fax +61 3 9345 4848.
Steatohepatitis/Metabolic Liver Disease
Version of Record online: 19 MAR 2009
Copyright © 2009 American Association for the Study of Liver Diseases
Volume 50, Issue 1, pages 94–101, July 2009
How to Cite
Gurrin, L. C., Bertalli, N. A., Dalton, G. W., Osborne, N. J., Constantine, C. C., McLaren, C. E., English, D. R., Gertig, D. M., Delatycki, M. B., Nicoll, A. J., Southey, M. C., Hopper, J. L., Giles, G. G., Anderson, G. J., Olynyk, J. K., Powell, L. W., Allen, K. J. and HealthIron Study Investigators (2009), HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity. Hepatology, 50: 94–101. doi: 10.1002/hep.22972
This article is dedicated to the memory of Ernest Beutler, who did much in recent years to stimulate interest in the natural history of hemochromatosis.
Potential conflict of interest: Nothing to report.
- Issue online: 23 JUN 2009
- Version of Record online: 19 MAR 2009
- Accepted manuscript online: 19 MAR 2009 12:00AM EST
- Manuscript Accepted: 11 MAR 2009
- Manuscript Received: 12 DEC 2008
- National Institute of Diabetes and Digestive and Kidney Diseases (USA). Grant Number: 1 RO1 DK061885-01 A2
- National Health and Medical Research Council (NHMRC, Australia). Grant Numbers: 251668, 209057
- Cancer Council Victoria
- NHMRC (Career Development Award, Practitioner Fellowship, Senior Research Fellowship, Australia Fellowship)